Anmol Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.71 M
- Revenue Growth 21.19%
- Profit Growth 0.42%
- Ebitda -322.78%
- Net Worth 34.52%
- Total Assets 42.47%
About Anmol Biotech
Anmol Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 June 2008 and has a history of 16 years and seven months. Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.71 M.
Alkeshbhai Chavda and Bhavanaben Chavada serve as directors at the Company.
Company Details
-
Location
Rajkot, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24120GJ2008PTC054233
-
Company No.
054233
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jun 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Anmol Biotech Private Limited offer?
Anmol Biotech Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Nitrogen Fertilizers, Insecticides and Pesticides, Insecticides, Termiticide, Bio Insecticides, Acaricide, Fungicides, Organic Fertilizers and Manure, Potassium Humate.
Who are the key members and board of directors at Anmol Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alkeshbhai Chavda
|
Director | 17-Jun-2008 | Current |
|
Bhavanaben Chavada
|
Director | 18-Jun-2010 | Current |
Financial Performance of Anmol Biotech.
Anmol Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.19% increase. The company also saw a slight improvement in profitability, with a 0.42% increase in profit. The company's net worth Soared by an impressive increase of 34.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anmol Biotech?
In 2019, Anmol Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.71 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2024 | Hdfc Bank Limited | ₹0.71 M | Open |
How Many Employees Work at Anmol Biotech?
Unlock and access historical data on people associated with Anmol Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anmol Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anmol Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
